As of Aug 28
| +1.21 / +2.60%|
The 4 analysts offering 12-month price forecasts for NewLink Genetics Corp have a median target of 62.00, with a high estimate of 65.00 and a low estimate of 50.00. The median estimate represents a +29.84% increase from the last price of 47.75.
The current consensus among 4 polled investment analysts is to Buy stock in NewLink Genetics Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.